For diabetic patients, drug interactions represent a significant toxicological concern. Certain medications, when combined, can amplify toxic effects or reduce therapeutic efficacy. For example, the use of non-steroidal anti-inflammatory drugs (NSAIDs) with sulfonylureas can increase the risk of hypoglycemia, a potentially dangerous complication.
